Tempest Therapeutics Inc (TPST)
3.18
-0.04
(-1.24%)
USD |
NASDAQ |
May 17, 16:00
3.18
0.00 (0.00%)
After-Hours: 20:00
Tempest Therapeutics Price: 3.18 for May 17, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 17, 2024 | 3.21 | 3.26 | 3.12 | 3.18 | 315402.0 |
May 16, 2024 | 3.35 | 3.36 | 3.22 | 3.22 | 229525.0 |
May 15, 2024 | 3.41 | 3.584 | 3.35 | 3.38 | 338109.0 |
May 14, 2024 | 3.25 | 3.45 | 3.245 | 3.40 | 441848.0 |
May 13, 2024 | 3.25 | 3.43 | 3.22 | 3.28 | 345717.0 |
May 10, 2024 | 3.54 | 3.560 | 3.17 | 3.25 | 490889.0 |
May 09, 2024 | 3.45 | 3.57 | 3.44 | 3.47 | 202084.0 |
May 08, 2024 | 3.52 | 3.55 | 3.44 | 3.47 | 298363.0 |
May 07, 2024 | 3.71 | 3.764 | 3.595 | 3.62 | 234117.0 |
May 06, 2024 | 3.75 | 3.79 | 3.60 | 3.73 | 213360.0 |
May 03, 2024 | 3.60 | 3.77 | 3.557 | 3.69 | 421053.0 |
May 02, 2024 | 3.67 | 3.74 | 3.48 | 3.54 | 482694.0 |
May 01, 2024 | 3.47 | 3.67 | 3.420 | 3.62 | 261662.0 |
Apr 30, 2024 | 3.44 | 3.54 | 3.39 | 3.47 | 246483.0 |
Apr 29, 2024 | 3.51 | 3.716 | 3.44 | 3.44 | 306788.0 |
Apr 26, 2024 | 3.51 | 3.63 | 3.38 | 3.54 | 402988.0 |
Apr 25, 2024 | 3.37 | 3.49 | 3.31 | 3.48 | 289664.0 |
Apr 24, 2024 | 3.45 | 3.57 | 3.36 | 3.44 | 652870.0 |
Apr 23, 2024 | 3.28 | 3.47 | 3.244 | 3.42 | 400752.0 |
Apr 22, 2024 | 3.10 | 3.28 | 3.08 | 3.24 | 391140.0 |
Apr 19, 2024 | 3.16 | 3.26 | 3.061 | 3.10 | 386258.0 |
Apr 18, 2024 | 3.30 | 3.34 | 3.17 | 3.17 | 316619.0 |
Apr 17, 2024 | 3.29 | 3.34 | 3.21 | 3.27 | 682179.0 |
Apr 16, 2024 | 3.32 | 3.44 | 3.20 | 3.35 | 471749.0 |
Apr 15, 2024 | 3.60 | 3.63 | 3.31 | 3.34 | 590868.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.23
Minimum
Oct 09 2023
249.60
Maximum
May 21 2019
31.24
Average
10.93
Median
Jul 07 2021
Price Benchmarks
CEL-SCI Corp | 1.27 |
AIM ImmunoTech Inc | 0.403 |
IGC Pharma Inc | 0.56 |
NovaBay Pharmaceuticals Inc | 0.1186 |
Protalix BioTherapeutics Inc | 1.14 |
Price Related Metrics
Price to Book Value | 3.424 |
Earnings Yield | -54.09% |
Market Cap | 70.65M |